Abstract
To discuss diagnostic strategies and management options in cases with suspected valsalva maculopathy (VM), to optimize visual outcome. We describe six cases with suspected VM. The preretinal hemorrhage resolved spontaneously in four out of six patients, without any intervention. One patient underwent neodymium-doped yttrium aluminum garnet hyaloidotomy and the other proceeded to have a vitrectomy for persistent diffuse vitreous hemorrhage. Considering the evidence available and the outcomes of our patients, we have devised a treatment algorithm for treating VM, which is elaborated in this article.
Keywords
Publication details
- DOI
- 10.4103/ojo.ojo_91_2016
- Journal
- Oman Journal of Ophthalmology, 11(1), 78-81
- Publisher
- Medknow Publications
- Open access
- Gold open access
Cite this article
APA 7
Mukherjee, C., Kumar, A., & Mitra, A. (2018). Valsalva maculopathy: To treat or not to treat. Oman Journal of Ophthalmology, 11(1), 78-81. https://doi.org/10.4103/ojo.ojo_91_2016
MLA 9
Mukherjee, Chandoshi, et al. "Valsalva maculopathy: To treat or not to treat." Oman Journal of Ophthalmology, vol. 11, no. 1, 2018, pp. 78-81. https://doi.org/10.4103/ojo.ojo_91_2016.
Chicago (author–date)
Mukherjee, Chandoshi, Ajith Kumar, and Arijit Mitra. 2018. "Valsalva maculopathy: To treat or not to treat." Oman Journal of Ophthalmology 11 (1): 78-81. https://doi.org/10.4103/ojo.ojo_91_2016.
Harvard
Mukherjee, C., Kumar, A. and Mitra, A. (2018) 'Valsalva maculopathy: To treat or not to treat', Oman Journal of Ophthalmology, 11(1), pp. 78-81. doi:10.4103/ojo.ojo_91_2016.
Vancouver
Mukherjee C, Kumar A, Mitra A. Valsalva maculopathy: To treat or not to treat. Oman Journal of Ophthalmology. 2018;11(1):78-81. doi:10.4103/ojo.ojo_91_2016
IEEE
C. Mukherjee, A. Kumar, and A. Mitra, "Valsalva maculopathy: To treat or not to treat," Oman Journal of Ophthalmology, vol. 11, no. 1, pp. 78-81, 2018, doi: 10.4103/ojo.ojo_91_2016.